Cardinal Health

Cardinal Health, Inc. is an integrated healthcare services and products company based in Dublin, Ohio, with operations in the United States and internationally. The company serves a wide range of healthcare providers, including hospitals, pharmacies, and clinical laboratories, through its two main segments: Pharmaceutical and Medical. The Pharmaceutical segment focuses on distributing branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter products, while also offering services such as medication therapy management and pharmacy management. The Medical segment manufactures and distributes a variety of medical, surgical, and laboratory products, including wound care and cardiovascular items, as well as providing supply chain solutions. Founded in 1979, Cardinal Health emphasizes customized solutions that enhance the performance of healthcare facilities and improve patient outcomes.

Kim Farmer

Director Network Services

Curt Witte

Senior Vice President / GM

62 past transactions

GI Alliance

Acquisition in 2024
GI Alliance is a network of gastroenterology specialists dedicated to delivering comprehensive care across all age groups. Founded in 2018 and headquartered in Southlake, Texas, the company aims to enhance clinical outcomes by bringing together top-tier gastroenterologists. Through its collaborative platform, GI Alliance fosters a high standard of care for patients, emphasizing the importance of specialized treatments in the field of gastroenterology.

Advanced Diabetes Supply

Acquisition in 2024
Advanced Diabetes Supply is a national distributor of Durable Medical Equipment focused on providing essential diabetes supplies to customers. The company offers a comprehensive range of products, including continuous glucose monitoring devices, insulin pumps, glucose meters, and insulin, facilitating convenient home delivery for individuals managing diabetes. Advanced Diabetes Supply is recognized for its commitment to quality, holding several esteemed accreditations within the diabetes supply industry, such as NABP and URAC. Through its innovative approach and dedication to exceptional service, the company aims to enhance customer outcomes and support the needs of those living with diabetes.

Integrated Oncology Network

Acquisition in 2024
Integrated Oncology Network is a prominent provider of oncology practice management and advisory services in the United States. The company specializes in offering comprehensive management solutions for cancer centers, hospitals, oncology groups, and physician practices. Its services encompass oncology center development, transaction services, project development, financing, and management, with a particular focus on radiation oncology operations. Integrated Oncology Network also provides essential administrative support, including billing and collection, accounting, compliance, and dosimetry services. By partnering with healthcare providers, the company aims to enhance operational efficiency and improve patient care within the oncology sector.

Innara Health

Acquisition in 2024
Innara Health, Inc. specializes in developing neonatal care technologies aimed at improving the health and development outcomes for preterm and full-term infants, as well as children with developmental needs. The company is best known for its NTrainer System, a medical device that supports the development of non-nutritive sucking skills in newborns, which is crucial for feeding. This system assists caregivers in neonatal and pediatric intensive care units by providing insights into effective treatment strategies for infants facing feeding challenges. Founded in 2006 and based in Olathe, Kansas, Innara Health was previously known as KCBioMedix, Inc. until it rebranded in 2013. The company’s innovations are focused on enhancing the quality of life for infants and their families, as well as improving overall feeding outcomes in hospital settings.

Specialty Networks

Acquisition in 2024
Specialty Networks is a U.S.-based organization that facilitates group purchasing for independent specialty healthcare providers, aiming to enhance their practices and improve patient outcomes. They offer a suite of services including population health management, patient engagement tools, clinical research support, and workflow automation technologies. By aggregating the purchasing power of its member providers and streamlining operations through technology, Specialty Networks helps its clients achieve operational excellence and transition towards value-based care models.

RxLive

Series A in 2022
RxLive, Inc. is a telehealth platform based in Saint Petersburg, Florida, that offers an online video chat service for counseling and concierge pharmacy services. Founded in 2017, the platform connects patients with clinical pharmacists to facilitate access to medications and provide comprehensive medication management. Through its services, RxLive aims to enhance patient care by ensuring that individuals receive personalized support and guidance regarding their medications.

Scala Med

Acquisition in 2022
ScalaMed has created the most transformative piece of real-estate in healthcare that embeds into any health App (B2B/SaaS), utilizing prescription fulfillment as the gateway of patient access & engagement.

Bendcare Management Services Organization

Corporate Round in 2022
Bendcare Management Services Organization provides management services.

Medically Home

Venture Round in 2022
Medically Home Group, Inc. is a Boston-based company that specializes in delivering virtual hospital services, enabling patients to receive medical care in the comfort of their homes. Founded in 2016, the company offers a comprehensive program that addresses various medical conditions, including heart failure, pneumonia, chronic obstructive pulmonary disease (COPD), and urinary tract infections, among others. By utilizing a technology-enabled platform, Medically Home connects patients with caregivers and facilitates monitoring and communication for individuals with high-acuity illnesses. This approach allows patients and their families to access centralized, on-demand acute medical care management, effectively shifting the focus of healthcare from traditional hospital settings to home-based care.

Ember LifeSciences

Corporate Round in 2021
Ember LifeSciences is transforming the logistics of temperature-sensitive pharmaceuticals with its innovative cold chain technology. The company's flagship product, the Ember Cube, is a self-refrigerated, cloud-based shipping box designed to ensure that life-saving medicines are transported within the required temperature range. This technology not only guarantees the integrity of the medicines upon arrival but also enables live tracking of shipments, enhancing transparency for businesses. By optimizing the shipping process, Ember aims to improve patient outcomes, save lives, and significantly reduce the millions of pounds of waste generated from traditional packing materials in the pharmaceutical industry.

Vineti

Series C in 2020
Vineti, Inc. is a technology company that specializes in developing solutions for the therapeutic delivery of personalized medicine, particularly focusing on cell and gene therapies. Founded in 2016 and headquartered in San Francisco, California, with additional offices in Bethesda, Maryland, and Yerevan, Armenia, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform streamlines and automates patient-centric supply chains, facilitating the efficient management of operations, manufacturing, quality control, and regulatory compliance for advanced therapies, including CAR-T cell therapies for late-stage cancer. Vineti's solutions aim to enhance patient access to life-saving treatments while addressing the challenges faced by patients, healthcare providers, pharmaceutical companies, and regulators in the commercialization of personalized medicine. By providing tools for supply chain orchestration and maintaining an audit trail for the handling of cell products, Vineti positions itself as a critical player in the evolving landscape of personalized therapeutics.

Vineti

Series C in 2020
Vineti, Inc. is a technology company that specializes in developing solutions for the therapeutic delivery of personalized medicine, particularly focusing on cell and gene therapies. Founded in 2016 and headquartered in San Francisco, California, with additional offices in Bethesda, Maryland, and Yerevan, Armenia, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform streamlines and automates patient-centric supply chains, facilitating the efficient management of operations, manufacturing, quality control, and regulatory compliance for advanced therapies, including CAR-T cell therapies for late-stage cancer. Vineti's solutions aim to enhance patient access to life-saving treatments while addressing the challenges faced by patients, healthcare providers, pharmaceutical companies, and regulators in the commercialization of personalized medicine. By providing tools for supply chain orchestration and maintaining an audit trail for the handling of cell products, Vineti positions itself as a critical player in the evolving landscape of personalized therapeutics.

Medically Home

Series B in 2019
Medically Home Group, Inc. is a Boston-based company that specializes in delivering virtual hospital services, enabling patients to receive medical care in the comfort of their homes. Founded in 2016, the company offers a comprehensive program that addresses various medical conditions, including heart failure, pneumonia, chronic obstructive pulmonary disease (COPD), and urinary tract infections, among others. By utilizing a technology-enabled platform, Medically Home connects patients with caregivers and facilitates monitoring and communication for individuals with high-acuity illnesses. This approach allows patients and their families to access centralized, on-demand acute medical care management, effectively shifting the focus of healthcare from traditional hospital settings to home-based care.

Mscripts

Acquisition in 2019
Mscripts, LLC specializes in developing mobile-based pharmacy solutions through a Software as a Service (SaaS) model. Founded in 2008 and headquartered in San Francisco, the company provides an online pharmacy transaction processing platform that connects mobile customers with pharmacy and prescription systems. This platform allows customers to manage their prescriptions, receive notifications, and communicate with their pharmacy via a two-way text messaging service. Mscripts aims to enhance patient engagement and adherence by delivering targeted messages and health information through mobile devices. In addition to its core services, the company also offers implementation, integration, customization, and customer support. As of 2019, Mscripts operates as a subsidiary of Cardinal Health, Inc.

Mirixa

Acquisition in 2019
Mirixa Corporation specializes in technology-enabled solutions for medication therapy management (MTM) services. Based in Reston, Virginia, the company provides MirixaPro, a web-based clinical platform that supports standardized patient care services and allows pharmacies to develop their own patient care programs. This platform includes templates for chronic disease management and enhanced documentation capabilities. Mirixa also offers productivity tools, resources for pharmacies, and an academic partnership program that connects colleges of pharmacy with educational opportunities to improve patient care. Additionally, the company manages pharmacy-delivered programs for health plans, such as formulary management and disease-specific coaching, and develops direct-to-patient medication management programs for pharmaceutical and biotech clients. Mirixa's technology is utilized by pharmacy benefit managers, health plans, and employers to implement standardized programs across various healthcare settings. Founded in 2006, the company was previously known as Community MTM Services, Inc. before rebranding in 2007.

NaviHealth

Venture Round in 2018
NaviHealth, Inc. is a provider of post-acute healthcare services that focuses on managing the entire post-acute care continuum in the United States. The company partners with health plans, hospitals, and post-acute providers to deliver comprehensive care management solutions. NaviHealth develops software and utilizes proprietary technology to support care transitions, providing clinical service support to optimize patient outcomes. Their approach includes evidence-based protocols, data analysis, and decision support tools that enhance care design and patient satisfaction while reducing hospital readmissions and inpatient days. Founded in 2011 and based in Brentwood, Tennessee, with additional offices in Massachusetts and Pennsylvania, NaviHealth operates as a subsidiary of OptumHealth, Inc.

Medtronic - Patient Monitoring & Recovery

Acquisition in 2017
Medtronic - Patient Monitoring & Recovery Division is a deep vein thrombosis and nutritional insufficiency businesses.

TelePharm

Acquisition in 2016
TelePharm is a digital healthcare company that provides a cloud-based telepharmacy platform designed to enhance the connection between pharmacies and patients. The platform enables hospital pharmacies to reach patients at home or other locations, facilitating convenient access to quality pharmaceutical care. Key features include pill counting, digital prescription verification, and counseling conducted through HIPAA-compliant, secure video calls. By streamlining workflows, TelePharm's solutions aim to improve productivity while delivering patient-focused pharmacy services.

RainTree Oncology Services

Acquisition in 2016
RainTree Oncology Services provides leading-edge oral drug acquisition and management services that make a difference in the lives of cancer patients by: helping community oncology practices expand services and improve patient care, enhancing the economic model of community oncology practices and pioneering an integrated information network between physicians, payors and manufacturers to advance the state of the art in oral oncology. RainTree Oncology is physician centric, patient focused and community minded.

Enlace Health

Series B in 2016
Enlace Health provides a comprehensive payment management platform that addresses the challenges within the healthcare reimbursement process. By connecting payers, providers, and patients, the company facilitates various healthcare delivery models, including both retrospective and prospective programs. Its platform analyzes existing healthcare data to create bundled payments and generate related reports, allowing healthcare providers to effectively manage delivery costs while promoting value-based care. Through these solutions, Enlace Health aims to improve the sustainability and efficiency of the healthcare system.

NaviHealth

Acquisition in 2015
NaviHealth, Inc. is a provider of post-acute healthcare services that focuses on managing the entire post-acute care continuum in the United States. The company partners with health plans, hospitals, and post-acute providers to deliver comprehensive care management solutions. NaviHealth develops software and utilizes proprietary technology to support care transitions, providing clinical service support to optimize patient outcomes. Their approach includes evidence-based protocols, data analysis, and decision support tools that enhance care design and patient satisfaction while reducing hospital readmissions and inpatient days. Founded in 2011 and based in Brentwood, Tennessee, with additional offices in Massachusetts and Pennsylvania, NaviHealth operates as a subsidiary of OptumHealth, Inc.

Outcomes Incorporated

Acquisition in 2015
Outcomes Incorporated is a national leader in designing, delivering, and administering Medication Therapy Management programs. Their services focus on advancing patient care and controlling utilization by providing patient-friendly face-to-face Personal Pharmacist™ services. With a commitment to cost-effective approaches, Outcomes Incorporated benefits health care purchasers by improving patient outcomes and streamlining medication management processes.

Cordis

Acquisition in 2015
Cordis Corporation, a subsidiary of Johnson & Johnson based in Miami Lakes, Florida, specializes in the development and manufacturing of interventional vascular medical devices. The company is renowned for its innovative and minimally invasive cardiovascular technology products, including drug-eluting stents, catheters, guidewires, and vena cava filters. These products are designed to treat coronary and peripheral vascular diseases, allowing healthcare providers such as pharmacies, hospitals, and outpatient surgical centers to prioritize patient care while improving efficiency and reducing costs. Cordis has established itself as a leader in the medical device industry through its commitment to technological advancement and a deep understanding of the healthcare landscape.

Emerge Medical

Acquisition in 2014
Emerge Medical, based in Denver, Colorado, specializes in the development, manufacturing, and distribution of orthopedic surgical devices and trauma products. The company offers a range of products, including plates, screws, total joint products, and guide wires, primarily aimed at hospitals and healthcare institutions. Emerge Medical is committed to reducing costs within the healthcare system, achieving cost savings of 40-60% for hospitals by streamlining the traditionally expensive processes associated with the medical device industry. This focus on cost efficiency positions Emerge Medical as a significant player in the orthopedic device market.

Access Closure

Acquisition in 2014
Access Closure, Inc. is a medical device company based in Mountain View, California, specializing in vascular closure solutions for interventional and diagnostic procedures. Founded in 2002, the company offers innovative products, including the Mynx delivery system. This device effectively seals arteriotomy sites using a water-soluble and extravascular sealant, which expands within the tissue by absorbing blood and subcutaneous fluids. Access Closure aims to simplify and enhance the process of vascular closure, addressing the complexities associated with these medical procedures.

KEW

Venture Round in 2014
KEW, Inc., established in 2009 and headquartered in Cambridge, Massachusetts, specializes in genomic testing services for cancer patients. The company's core offering, CANCERPLEX, is a precision medicine service that analyzes a patient's genetic drivers to help oncologists select personalized, targeted therapies. KEW's suite of products includes CANCERPLEX FP, a full panel test with immunotherapy options, CANCERPLEX TS for common tumor sites, and CANCERPLEX TX for FDA-approved targeted therapies. The company delivers these solutions through strategic partnerships and distributors, enabling evidence-driven treatment decisions in cancer care.

Wavemark

Acquisition in 2013
WaveMark, Inc. provides information products that enable hospitals and manufacturers to control and manage the flow of consumable medical devices. Its product enables to capture, store, and provide data via Web browser for manufacturers and hospitals. The company uses radio frequency identification technology to collect and report real time information in a hands free environment. WaveMark, Inc. was founded in 2003 and is based in Littleton, Massachusetts

HealthSpot

Venture Round in 2013
HealthSpot mission is to increase access to high quality, convenient and affordable healthcare services. We do this with the innovative application of technology to healthcare. Our telemedicine Care4 Station is the ultimate access point to better healthcare, using our powerful custom software platform to bring together patients and providers in convenient neighborhood locations. We have the tools to empower healthcare professionals, making healthcare smarter, simpler and more accessible for everyone. HealthSpot files for bankruptcy on Jan, 2016.

AssuraMed

Acquisition in 2013
AssuraMed is a direct-to-customer provider specializing in disposable medical products for patients with chronic diseases. The company operates through two primary segments: Independence Medical and Edgepark Medical Supplies. Independence Medical acts as an outsourced supply chain for over 12,000 commercial customers, including durable medical equipment suppliers, independent pharmacies, and wholesale distributors. Edgepark collaborates directly with over 600 managed care organizations to deliver medical supplies to patients' homes, offering services that enhance utilization, billing efficiencies, and patient compliance. AssuraMed's product range includes supplies for ostomy care, diabetes management, urological issues, incontinence, respiratory care, and wound care, catering to managed care beneficiaries, home care supply providers, and healthcare professionals.

MCD

Acquisition in 2012
MCD is a company that was acquired by Cardinal Health in 2012.

Dik Drug

Acquisition in 2012
Dik Drug is a company that was acquired by Cardinal Health in 2012.

Futuremed Health Care Products

Acquisition in 2011
Distributor of consumable nursing supplies.

Zuellig Pharma

Acquisition in 2010
Zuellig Pharma is a leading provider of distribution and digital services in the healthcare sector, operating in Asia since 1922. The company serves 13 countries and regions, offering a comprehensive range of solutions to healthcare partners. Its services include the distribution of pharmaceuticals, medical devices, and clinical trial materials, as well as sales and marketing outsourcing, patient-centered programs, and retail pharmacy services. By delivering tailored solutions and critical market insights, Zuellig Pharma helps clients navigate the dynamic healthcare landscape and maximize their market potential in the rapidly growing Asian markets.

Kinray

Acquisition in 2010
Kinray is a distributor specializing in pharmaceutical and healthcare products, including generics, health and beauty aids, home health care items, vitamins, and medical candies. The company has established a strong reputation for providing dependable service to independent pharmacy customers. As a full-service wholesaler, Kinray focuses on delivering timely and courteous support to ensure customer satisfaction. With a commitment to quality and reliability, Kinray continues to be a trusted partner in the healthcare distribution sector.

HLS Freight Services

Acquisition in 2010
HLS Freight Services is a company that was acquired by Cardinal Health in 2010.

Healthcare Solutions Holding

Acquisition in 2010
Provides health care management solutions that help patients' health care outcomes and in the delivery of health care services.

Borschow Hospital & Medical Supplies

Acquisition in 2008
Borschow Hospital & Medical Supplies, Inc. is the largest and most technologically-advanced distributor of pharmaceutical products.

Enturia

Acquisition in 2008
ChloraPrep® brand products are used widely in U.S. hospitals and surgery centers to disinfect the skin before surgical and vascular procedures to help prevent blood stream and surgical site infections, two of the most common types of health care-associated infections (HAIs) among patients.

Viasys Healthcare

Acquisition in 2007
Viasys Healthcare is a healthcare company headquartered in Geispolsheim-Gare, France, that specializes in respiratory, neuro-care, and medical/surgical technologies. Founded in 1995 by Douglas DeVries and Randy Thurman, Viasys Healthcare manufactures and distributes a range of medical products and instruments. Its offerings include respiratory and neurology products, medical disposables, sleep therapy devices, and orthopedic solutions, all designed to diagnose various disorders, including neurological, auditory, and cardiovascular conditions. The company aims to enhance healthcare safety while providing immediate revenue opportunities through its research-based medical technology solutions.

CareFusion

Acquisition in 2006
CareFusion is a provider of medical products and enterprise management solutions aimed at enhancing the safety and cost-effectiveness of healthcare. The company offers a range of medical technology products, including automated dispensing systems, patient identification solutions, respiratory ventilators, and surgical instruments that are essential for infection prevention, neurological monitoring, and diagnosis. By focusing on these areas, CareFusion assists healthcare organizations in achieving improvements in infection control, medication management, medical supply management, and respiratory care.

MedMined

Acquisition in 2006
MedMined, Inc. provides data mining analysis and related technical, clinical, and financial consulting services to the healthcare community.

ParMed Pharmaceuticals

Acquisition in 2006
ParMed Pharmaceuticals is a distributor of generic pharmaceuticals and medical supplies based in Niagara Falls, New York. With a history spanning 47 years, the company is recognized for providing high-quality pharmaceuticals, including tablets, capsules, and liquids. In addition to pharmaceuticals, ParMed offers a range of medical, laboratory, and surgical products, emphasizing competitive pricing and superior customer service.

Nitric Bio

Series A in 2006
NitricBio is a mid-stage specialty pharmaceutical company focused on the dermatology and podiatry markets, with two unique drug delivery technologies. The first technology involves the development and commercialization of topical nitric oxide gas. Nitric oxide has both direct and regulatory actions with known anti-infective and anti-inflammatory properties. The company's current focus is on the development of a treatment for moderate-to-severe tinea pedis (athlete's foot), which is currently in late Phase 2 clinical trials.

Denver Biomedical

Acquisition in 2006
Denver Biomedical, Inc. engages in the design, manufacture, and distribution of specialized medical products.

Geodax Technology

Acquisition in 2004
Geodax Technology firm owns and operates pharmacies.

Alaris Medical Systems

Acquisition in 2004
ALARIS Medical Systems ( www.alarismed.com ) develops and markets products for the safe delivery of intravenous (IV) medications. The Company's IV medication and infusion therapy delivery systems, software applications, needle-free disposables and related monitoring equipment are marketed in the United States and internationally. ALARIS' "smart" pumps, with the proprietary Guardrails(R) Safety Software, help to reduce the risks and costs of medication errors, help to safeguard patients and clinicians and gather and record clinical information for review, analysis and interpretation. The Company provides its products, professional and technical support and training services to over 5,000 hospital and health care systems, as well as alternative care sites, in more than 120 countries through its direct sales force and distributors.

Gala Biotech

Acquisition in 2003
Gala Biotech, established in 1996 and located in Middleton, Wisconsin, specializes in biopharmaceutical manufacturing and molecular biology. The company, which has grown to over 40 employees, including 16 PhDs, is known for its proprietary GPEx® technology, which facilitates the rapid creation of stable, high-expressing mammalian cell lines for various gene products. Originally focused on producing pharmaceutical proteins in the milk of transgenic cows, Gala has adapted its gene insertion technology to support the increasing demand for the discovery and stable expression of therapeutic proteins. This technology plays a crucial role in helping biotech researchers overcome the challenges associated with clinical development. To enhance its capabilities, Gala has established a 43,000 square-foot facility dedicated to GPEx®-based cell line development and cGMP-compliant protein production, reinforcing its commitment to meeting the needs of its biopharmaceutical partners.

Syncor

Acquisition in 2002
Syncor International Corporation specializes in high technology healthcare services, focusing on nuclear pharmacy, medical imaging, niche manufacturing, and radiotherapy. In nuclear pharmacy, Syncor compounds and dispenses radiopharmaceuticals for both diagnostic and therapeutic applications, serving over 7,000 customers across the United States via an extensive network of 130 domestic and 19 international pharmacies. The company also provides medical imaging services through 72 domestic and 19 international facilities, managed by its subsidiary, Comprehensive Medical Imaging, Inc. Additionally, Syncor operates eight domestic and two international production sites for positron emission tomography (PET) radiopharmaceuticals and engages in agreements to enhance the accessibility of PET technology for healthcare providers and patients nationwide.

Boron, LePore & Associates

Acquisition in 2002
Boron LePore & Associates, Inc., provides integrated medical education to the health care industry. The company's services include strategic consultation, content development, accredited and non-accredited program development and execution, logistics management and a variety of internet-based solutions related to these services.

Magellan Laboratories

Acquisition in 2002
Magellan develops and tests early-stage drugs for more than 200 pharmaceutical and biotechnology companies,

Bindley Western Industries

Acquisition in 2000
Bindley Western Industries is a pharmaceutical distribution and services company.

Bergen Brunswig Corp

Acquisition in 2000
Bergen Brunswig Corporation ( www.bergenbrunswig.com ) is a supplier of pharmaceuticals, medical- surgical supplies and specialty health-care products as well as information management solutions and consulting services.

Esurg.com

Series B in 2000
Esurg.com, the most comprehensive and trusted online source for medical, surgical and pharmaceutical supplies and information. They designed Their Web site for the growing number of physician practices and clinics working outside traditional hospital settings — to give them an edge in the increasingly complex business of medicine.

WiseBear.com

Series A in 2000
WiseBear.com is an e-commerce platform and online community focused on helping people lead a more balanced life. The company was founded in 1999 and is based in New York, United States.

Automatic Liquid Packaging

Acquisition in 1999
Automatic Liquid Packaging is a manufacturer of sterile liquid pharmaceuticals and other health-care products in topical, oral, inhaled and ophthalmic formulations.

Allegiance Healthcare

Acquisition in 1999
Allegiance Healthcare is a Health Care company.

R.P. Scherer Corporation

Acquisition in 1998
An international oral drug delivery systems company.

Owen Healthcare

Acquisition in 1996
A provider of outsourced management services for hospital pharmacies and materials management departments.

PCI Pharma Services

Acquisition in 1996
PCI Pharma Services is an integrated full-service provider and trusted partner to leading companies in the global healthcare industry. With unparalleled expertise and experience, PCI takes compounds from the earliest stages of development through to commercial launch, delivering speed to market and commercial success for their customers.

Pyxis Corporation

Acquisition in 1996
Pyxis offers a range of behavioral health services for its customers. Its services include pro-social skills acquisition, psychosocial rehabilitation, life skills training, tutoring, mentoring, parent support and coaching, family mentoring, attendant care, respite care, intensive in-home, crisis intervention, and support services. It facilitates behavioral aide, after school group support, and day camps. Pyxis was acquired by Cardinal Health in February 1996. Pyxis Corporation was founded in 1994.

Medicine Shoppe International

Acquisition in 1995
Medicine Shoppe International operates a pharmacy chain established in 1968 by St. Louis pharmacist Michael Busch. The company is dedicated to providing personalized service through pharmacist-managed operations, allowing for a focus on customer needs. Medicine Shoppe pharmacies cater to a wide range of health conditions, offering medications for diseases such as cancer, Alzheimer's, depression, congestive heart failure, asthma, osteoarthritis, and anxiety disorders. The business model has demonstrated success by prioritizing both customer care and operational efficiency, making it a notable presence in the United States pharmacy landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.